Behavioral characterization of mdx3cv mice deficient in C-terminal dystrophins

Neuromuscular Disorders

Volumn 9, Issue 5, 1999, Pages 296-304

  Vaillend, Cyrille ^a   Ungerer, Arielle ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Animal model; Anxiety related behavior; Dystrophin gene products; Extinction; Learning; mdx mouse; mdx3cv mouse; Memory; Spontaneous locomotor activity

Indexed keywords

DYSTROPHIN;

ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; COGNITIVE DEFECT; CONTROLLED STUDY; LEARNING DISORDER; LOCOMOTION; MALE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DYSTROPHIN; EMOTIONS; EXTINCTION, PSYCHOLOGICAL; FEMALE; LEARNING; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MOTOR ACTIVITY; MOTOR SKILLS; MUSCULAR DYSTROPHY, ANIMAL; PROTEIN ISOFORMS;

EID: 0033005157     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(99)00029-2     Document Type: Article

References (39)

1. Hoffman E.P., Brown R.H.J., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 51:1987;919-928.
2. Nicholson L.V.B., Johnson M.A., Bushby K.M.D, et al. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients. J Med Genet. 30:1993;737-744.
3. Billard C., Gillet P., Signoret J.L., et al. Cognitive functions in Duchenne muscular dystrophy: a reappraisal and comparison with spinal muscular atrophy. Neuromusc Disord. 2:1992;371-378.
4. Emery A.E.H. Duchenne muscular dystrophy. 2 :1993;1 Oxford University Press, New York.
5. Nudel U., Zuk D., Einat P., et al. Duchenne muscular dystrophy gene product is not identical in muscle and brain. Nature. 337:1989;76-78.
6. Lidov H.G.W. Dystrophin in the nervous system. Brain Pathol. 6:1996;63-77.
7. Dubowitz V., Crome L. The central nervous system in Duchenne muscular dystrophy. Brain. 92:1969;805-808.
8. Rapaport D., Passos-Bueno M.R., Brandao L. Love D., Vainzof, M., Zatz, M., Apparent association of mental retardation and specific patterns of deletions screened with probes cf56a and cf23a in Duchenne muscular dystrophy. Am J Med Genet. 39:1991;437-441.
9. Lenk U., Hanke R., Thiele H., Speer A. Point mutations at the carboxy terminus of the human dystrophin gene: implications for an association with mental retardation in DMD patients. Hum Mol Gen. 2:1993;1877-1881.
10. Bushby K.M.D, Appleton R., Anderson L.V.B., Welch J.L., Kelly P., Gardner-Medwin D. Deletion status and intellectual impairment in Duchenne muscular dystrophy. Dev Med Child Neurol. 37:1995;260-269.
11. Bulfield G., Siller W.G., Wight P.A.L., Moore K.J. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA. 81:1984;1189-1192.
12. Sicinski P., Geng Y., Ryder-Cook A.S., Barnard E.A., Darlison M.G., Barnard P.J. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science. 244:1989;1578-1580.
13. Muntoni F., Mateddu A., Serra G. Passive avoidance behaviour deficit in the mdx mouse. Neuromusc Disord. 1:1991;121-123.
14. Vaillend C., Rendon A., Misslin R., Ungerer A. Influence of dystrophin-gene mutation on mdx mice behavior. I. Retention deficits at long delays in spontaneous alternation and bar-pressing tasks. Behav Genet. 25:1995;569-579.
15. Sesay A.K., Errington M.L., Levita L., Bliss T.V.P. Spatial learning and hippocampal long-term potentiation are not impaired in mdx mice. Neurosci Lett. 211:1996;207-210.
16. Vaillend C., Billard J.M., Claudepierre T., Rendon A., Dutar P. Ungerer A., Spatial discrimination learning and CA1 hippocampal synaptic plasticity in mdx and mdx3cv mice lacking dystrophin gene products. Neuroscience. 86:1998;53-66.
17. Cox G.A., Phelps S.F., Chapman V.M., Chamberlain J.S. New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin. Nature Genet. 4:1993;87-93.
18. Pastoret C., Sebille A. Mdx mice show progressive weakness and muscle degeneration with age. J Neurol Sci. 129:1995;97-105.
19. Im W.B., Phelps S.F., Copen E.H., Adams E.G., Slightom J.L., Chamberlain J.S. Differential expression of dystrophin isoforms in strains of mdx mice with different mutations. Hum Mol Genet. 5:1996;1149-1153.
20. Bouton M.E. Conditioning, remembering and forgetting. J Exp Psychol. 20:1994;219-231.
21. Lassalle J.-M. Neurogenetic basis of cognition: facts and hypotheses. Behav Process. 35:1996;5-18.
22. Misslin R., Ropartz P. Effects of lateral amygdala lesions on the responses to novelty in mice. Behav Process. 6:1981;329-336.
23. Douglas R.J., Isaacson R.L. Homogeneity of single trial response tendencies and spontaneous alternation in the T-maze. Psychol Rep. 16:1965;87-92.
24. Durantou F., Cazala P., Jaffard R. Intertrial interval dependent effect of lateral hypothalamic stimulation on spontaneous alternation behavior in a T-maze. Physiol Behav. 46:1989;253-258.
25. Padeh B., Wahlsten D., DeFries J.C. Operant discrimination learning and operant bar-pressing rates in inbred and heterogeneous laboratory mice. Behav Genet. 4:1974;383-393.
26. Dickinson A., Balleine B. Motivational control of goal-directed action. Anim Learn Behav. 22:1994;1-18.
27. Pearce J.M. Instrumental conditioning. Animal learning and cognition. An introduction. 2 :1997;81 Psychology Press, UK.
28. Kimble D.P., Kimble R.J. The effect of hippocampal lesions on extinction and 'hypothesis' behavior in rats. Physiol Behav. 5:1970;735-738.
29. Belzung C. Hippocampal mossy fibres: implication in novelty reactions or in anxiety behaviours? Behav Brain Res. 51:1992;149-155.
30. Dodson H.C., Piper T.A., Clarke J.D., Quinlivan R.M., Dickson G. Dystrophin expression in the hair cells of the cochlea. J Neurocytol. 24:1995;625-632.
31. Pillers D.A.M., Bulman D.E., Weleber R.G., et al. Dystrophin expression in the human retina is required for normal function as defined by electroretinography. Nature Genet. 4:1993;82-86.
32. Kim T.W., Wu K., Xu J.L., Black I.B. Detection of dystrophin in the post-synaptic density of rat brain and deficiency in a mouse model of Duchenne muscular dystrophy. Proc Natl Acad Sci USA. 89:1992;11642-11644.
33. Cibis G.W., Fitzgerald K.M., Harris D.J., Rothberg P.G., Rupani M. The effects of dystrophin gene mutations on the ERG in mice and humans. Invest Ophthalmol Visual Sci. 34:1993;3646-3652.
34. Pillers D.A.M., Weleber R.G., Woodward W.R., Green D.G., Chapman V.M., Ray P.N. Mdx (Cv3) mouse is a model for electroretinography of Duchenne muscular dystrophy. Invest Ophthalmol Visual Sci. 36:1995;462-466.
35. Sigesmund D.A., Weleber R.G., Pillers D.A.M., et al. Characterization of the ocular phenotype of Duchenne and Becker muscular dystrophy. Ophthalmology. 101:1994;856-865.
36. Griebel G., Belzung C., Misslin R., Vogel E. The free-exploratory paradigm: an effective method for measuring neophobic behavior in mice and testing potential neophobia-reducing drugs. Behav Pharmacol. 4:1993;637-644.
37. Sadoulet-Puccio H.M., Kunkel L.M. Dystrophin and its isoforms. Brain Pathol. 6:1996;25-35.
38. Crawley J.N. Unusual behavioral phenotypes of inbred mouse strains. Trends Neurosci. 19:1996;181-182.
39. Bresolin N., Castelli E., Comi G.P., et al. Cognitive impairment in Duchenne muscular dystrophy. Neuromusc Disord. 4:1994;359-369.